Premotor Parkinson's disease: Clinical features and detection strategies

Movement Disorders

Volumn 24, Issue SUPPL. 2, 2009, Pages

  Stephenson, Randolph ^a   Siderowf, Andrew ^a   Stern, Matthew B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Early detection; Molecular imaging; Olfaction; Parkinson's disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE; 6 FLUORODOPA F 18; LEUCINE RICH REPEAT KINASE 2; PARKIN;

ANXIETY; ARTICLE; CLINICAL FEATURE; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INTROVERSION; MEDICAL RESEARCH; MOTOR DYSFUNCTION; NEUROIMAGING; OLFACTORY DISCRIMINATION; OUTCOME ASSESSMENT; PARASOMNIA; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT SAFETY; PERSONALITY DISORDER; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMELLING DISORDER;

GENETIC TECHNIQUES; HUMANS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; ULTRASONICS;

EID: 72849125110     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22403     Document Type: Article

References (46)

1. Langston JW. The Parkinson's complex: Parkinsonism is just the tip of the iceberg. Ann Neurol 2006;59:591-596.
2. Louis ED, Bennett DA. Mild parkinsonian signs: an overview of an emerging concept. Mov Disord 2007;22:1681-1688.
3. Stern MB. The preclinical detection of Parkinson's disease: ready for prime time? Ann Neurol 2004;56:169-171.
4. Siderowf A, Stern MB. Preclinical diagnosis of Parkinson's disease: are we there yet? Curr Neurol Neurosci Rep 2006;6:295-301.
5. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. Neurol Neurosurg Psychiatry 1992;55:181-184.
6. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc 2004;52:784-788. (Pubitemid 38596500)
7. Arabia G, Grossardt BR, Geda YE, et al. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson's disease. Arch Gen Psychiatry 2007;64:1385-1392. (Pubitemid 350223556)
8. Leentjens AFG, Van den Akker M, Metsemakers JFM, Lousberg R, Verhey FRJ. Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 2003;18:414-418. (Pubitemid 36527282)
9. Shiba M, Bower JH, Maraganore DM, et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 2000;15:669-677. (Pubitemid 30479619)
10. Glosser G, Clark C, Freundlich B, Kliner-Krenzel L, Flaherty P, Stern M. A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients. Mov Disord 1995;10:201-206.
11. Abbott RD, Ross GW, White LR, et al. Excessive daytime sleepiness and subsequent development of Parkinson's disease. Neurology 2005;65:1442.
12. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain 2000;123:1155-1160.
13. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996;46:388-393. (Pubitemid 126425731)
14. Plazzi G, Cortelli P, Montagna P, et al. REM sleep behavior disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure. J Neurol Neurosurg Psychiatry 1998;64:683-685. (Pubitemid 28204163)
15. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in Parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988;38:1237-1244. (Pubitemid 18218608)
16. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211. (Pubitemid 36007810)
17. Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 1993;43:962-965. (Pubitemid 23150569)
18. Khan NL, Katzenschlager R, Watt H, et al. Olfaction differentiates parkin disease from early-onset Parkinsonism and Parkinson's disease. Neurology 2004;62:1224-1226. (Pubitemid 38456528)
19. Khan NL, Jain S, Lynch JM, et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 2005;128:2786-2796. (Pubitemid 41746633)
20. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism. Nature 1998;392:605-608. (Pubitemid 28207717)
21. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med 2000;342:1560-1567. (Pubitemid 30340501)
22. Clark LN, Afridi S, Karlins E, et al. Case-control study of the parkin gene in early-onset Parkinson's disease. Arch Neurol 2006;63:548-552.
23. Rajput A, Dickson DW, Robinson CA, et al. Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 2006;67:1506-1508.
24. Giasson BI, Covy JP, Bonini NM, et al. Biochemical and pathological characterization of LRRK2. Ann Neurol 2006;59:315-322.
25. Jennings DL, Seibyl JP, Oakes D, Eberly S, Murphy J, Marek K. (123I) b-CIT and single-photon emission computed tomographic imaging vs. clinical evaluation in parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol 2004;61:1224-1229. (Pubitemid 39062674)
26. Marek KL, Seibyl JP, Zoghbi SS, et al. [123I] b-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology 1996;46:231-237. (Pubitemid 126425728)
27. Holthoff VA, Vieregge P, Kessler J, et al. Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol 1994;36:176-182. (Pubitemid 24239234)
28. Piccini P, Burn DJ, Ceravolo R, et al. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 1999;45:577-582. (Pubitemid 29217585)
29. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995;45:182-184.
30. Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001;248:684-689. (Pubitemid 32695865)
31. Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003;60:74-77. (Pubitemid 36070647)
32. Ruprecht-Dorfler P, Berg D, Tucha O, et al. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage 2003;18:416-422. (Pubitemid 36269151)
33. Braune S, Reinhardt M, Bathmann J, Krause T, Lehmann M, Lucking CH. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand 1998;97:307-314. (Pubitemid 28191923)
34. Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999;53:1020-1025.
35. Courbon F, Brefel-Courbon C, Thalamas C, et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Mov Disord 2003;18:890-897. (Pubitemid 37021163)
36. Morens DM, Grandinetti A, Waslien CI, Park CB, Ross GW, White LR. Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake. Neurology 1996;46:1270-1274. (Pubitemid 26159285)
37. Thacker EL, O'Reilly EJ, Weisskopf MG, et al. Temporal relationship between cigarette smoking and risk of Parkinson's disease. Neurology 2007;68:764-768. (Pubitemid 46667902)
38. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT, Jr, Swanson PD. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002;155:732-738. (Pubitemid 34297653)
39. Tanner CM, Goldman SM, Aston DA, et al. Smoking and Parkinson's disease in twins. Neurology 2002;58:581-588.
40. Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with risk of Parkinson's disease. JAMA 2000;283:2674-2679. (Pubitemid 30337329)
41. Abbott RD, Ross GW, White LR, et al. Midlife adiposity and the future risk of Parkinson's disease. Neurology 2002;57:1051-1057.
42. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001;57:456-462. (Pubitemid 32757593)
43. Ascherio A, Chen H, Weisskopf MG, et al. Pesticide exposure and risk for Parkinson's disease. Ann Neurol 2006;60:187-203.
44. Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration 1995;4:93-97.
45. Siderowf A, Newberg AB, Chou KL, et al. TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson's disease. Neurology 2005;64:1716-1720. (Pubitemid 40695804)
46. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BLF, Wolters EC, Berendse HW. Idiopathic Hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-181. (Pubitemid 39037913)